Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Pfizer Launches App for Patients with Depression

XTALKS VITALS NEWS

App

Pfizer’s app – known as Moodivator – helps patients track their daily moods, and share goals with their healthcare provider to help them make progress in their treatment.

Share this!

December 20, 2016 | by Sarah Hand, M.Sc.

Drugmakers are gradually breaking into the popular health app space, with big pharmaceutical company, Pfizer, launching its mood tracking app for people with depression. While the app is linked to Pfizer’s depression medication, Pristiq, it is not a medication adherence tool like Eli Lilly’s Trulicity app.

Pfizer’s app – known as Moodivator – helps patients track their daily moods, and share goals with their healthcare provider to help them make progress in their treatment. According to app analytics platform Sensor Tower, the Moodivator app has been downloaded less than 5,000 times since its launch in September.

“Moodivator is designed to motivate patients and help complement their treatment by allowing patients to track their mood, set goals, and establish routines that can help support them in their daily life,” said Julie Ferguson, senior manager of communications for Pfizer. “This is important because even seemingly small tasks can feel difficult for people with depression. Patients receive encouraging inspirational messages in the app to help motivate them along the way.”



While the app does contain information about Pfizer’s Pristiq, patients do not need to be prescribed the depression drug in order to use the app. According to Ferguson, the app is helpful for patients who are unable to attend in-person therapy sessions but need a way to manage and keep track of the progress of their depression.

“Advances in technology are now offering patients new tools to help them as they manage their depression,” said Ferguson. “We developed the Moodivator app in consultation with psychiatrists to help complement a patient’s treatment by providing ongoing motivation in a simple, efficient, and portable way for those living with depression.”

Pfizer also offers patient support to users of Pristiq through a program known as the Wind Up. This is a service which sends motivational messages as well as prescription refill reminders to patients via email, regular mail and text messages.


Keywords: Pfizer, Depression, Health App


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News


Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News


Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

One Patient’s Perspective on Clinical Trials

REGISTER FOR THESE WEBINARS

Planning and Conducting Trials of the Latest Immunotherapies


ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation


Medical Devices: Reviewing Regulatory Changes in the US and EU


Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.